Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Malignant

Explore clinical trials studying Neoplasm Malignant. Study availability and eligibility vary by location and protocol.

37 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Malignant trial results

Completed

Effect of SAR302503 on ECG Activity in Patients With Solid Tumors

NCT01836705

Conditions
Neoplasm Malignant, Neoplasms
Locations
  • Investigational Site Number 840003 Los Angeles, California, United States
  • Investigational Site Number 840007 Augusta, Georgia, United States
  • Investigational Site Number 840002 Detroit, Michigan, United States
  • Investigational Site Number 840001 St Louis, Missouri, United States
View Trial Details
Completed

COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.

NCT03667716

Conditions
Adnexal Diseases, Advanced Cancer, Breast Cancer, +44 more
Locations
  • University of California Los Angeles (UCLA). Los Angeles, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma

NCT04200963

Conditions
Advanced Cancer, Advanced Solid Tumor, Bladder Cancer, +35 more
Locations
  • Banner Health- MD Anderson Cancer Center Gilbert, Arizona, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Johns Hopkins Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen

NCT01587040

Conditions
Neoplasm Malignant, Neoplasms
Locations
  • Investigational Site Number 840010 Birmingham, Alabama, United States
  • Investigational Site Number 840009 Los Angeles, California, United States
  • Investigational Site Number 840008 Los Angeles, California, United States
  • Investigational Site Number 840022 Denver, Colorado, United States
View all 21 locations
View Trial Details
Completed

Evaluation of End of Life Quality of Care

NCT03775304

Conditions
End of Life Care, Neoplasm Malignant, Neoplasms, +1 more
Locations
  • APHP Hôpital Cochin Paris, France
  • APHP Hôpital Européen Georges Pompidou Paris, France
  • APHP Hôpital Henri Mondor Paris, France
  • Institut Gustave Roussy Villejuif, France
View Trial Details
Completed

Phase 1 Safety Testing of SAR405838

NCT01636479

Conditions
Neoplasm Malignant, Neoplasms
Locations
  • Investigational Site Number 840101 Boston, Massachusetts, United States
  • Investigational Site Number 840001 Boston, Massachusetts, United States
  • Investigational Site Number 840002 New York, United States
  • Investigational Site Number 250001 Villejuif, France
View Trial Details

Related conditions